Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions Supports Global Industry Response to H1N1 Flu Outbreak
May 20th, 2009
Catalent Pharma Solutions, Inc., the leading provider of outsourced dose form manufacturing and packaging services to the global pharmaceutical, biotechnology and consumer health industry, expects to play a vital role in supporting the global pharmaceutical and biotechnology industry response to the expanding influenza A (H1N1, or swine) influenza outbreak. Catalent has existing customer agreements to produce on demand substantial additional commercial supplies for anti-viral drugs currently recommended by the US Centers for Disease Control and Prevention to treat H1N1 type flu. Catalent is also one of the leading outsourcing providers of prefilled syringe filling for...
Source: Vaccine Weekly (2009-05-20)
|
